ARS Pharmaceuticals SPRY SEC Filings

NASDAQ SPRY
$5.61 -0.06 (-0.97%)
As of: Sep 4, 2026 · 2:24 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document ARS Pharmaceuticals, Inc. (SPRY) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index